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Three discrete forms of feline leukemia virus (FeLV)-associated lymphoma have been described clinically: (1) thymic, (2)
alimentary, and (3) multicentric. The most common and best-characterized lymphomas are of T-cell origin, generally occurring
in the thymus. These tumors typically contain mature T-cells, involve the activation of a distinctive set of proto-oncogenes,
and contain FeLV proviruses whose long terminal repeat (LTR) sequences contain tandemly repeated enhancers. Previous
studies of a small group of extrathymic, multicentric lymphomas implicated a different set of genetic determinants. The
present study expands those observations by examining the lineage of origin, the involvement of proto-oncogenes, and the
structure of LTR and env gene sequences in a set of 11 natural, extrathymic lymphomas of the multicentric type. A pattern
of genetic events associated with FeLV-positive multicentric lymphomas emerges from this analysis that is clearly distinct
from the pattern associated with thymic lymphomas. The tumors do not contain T-cells or B-cells, as evidenced by the
germ line organization of TCRb and IgH loci. Proto-oncogenes strongly implicated in T-cell lymphomagenesis are not
involved in these tumors. Rather, a distinct set of proto-oncogenes may be involved. Most striking is the repeated occurrence
of an FeLV isolate whose LTR and env gene bear unique sequence elements. q 1995 Academic Press, Inc.
INTRODUCTION been well documented (Levy and Lobelle-Rich, 1992;
Levy et al., 1993a,b; Tsujimoto et al., 1993; Tsatsanis et
The feline leukemia viruses (FeLV) are a family of hori- al., 1994). Finally, the FeLV proviruses cloned directly
zontally transmissible retroviruses of the domestic cat, from thymic tumors are distinctive in that their long termi-
associated with a wide range of malignant diseases in nal repeat (LTR) sequences typically contain tandemly
the natural host. The most frequently associated malig- repeated enhancers, generally as 2 or 3 directly repeated
nancy is a lymphoma characterized by the presence of copies (Fulton et al., 1990; Matsumoto et al., 1992; Rohn
discrete tumors and diffuse infiltration of organs by and Overbaugh, 1995). The results of a recent study of
lymphoid tumor cells. Three forms of FeLV-associated FeLV-induced T-cell lymphomagenesis suggested a hier-
lymphoma have been described clinically: (1) thymic, archy of genetic events involving these determinants
characterized by a rapidly progressive tumor of the ante- (Tsatsanis et al., 1994).
rior mediastinum; (2) alimentary, in which the tumor in- Previous studies of a small group of extrathymic
volves the gastrointestinal tract; and (3) multicentric, a lymphomas implicated a different set of genetic determi-
generalized disease involving many lymphoid tissues nants. In particular, a group of four tumors was examined,
and other organs (Crighton, 1969; Cotter, 1992). The most all of which had been isolated from the spleens of dis-
common and best-characterized lymphomas are of T-cell eased animals. These tumors were shown not to contain
origin, generally occurring in the thymus (Neil et al., 1991; mature T-cells or B-cells, as evidenced by the germ line
Jarrett, 1992). Extensive examination of the molecular ba- organization of TCRb and immunoglobulin heavy chain
sis of these lymphomas has identified several genetic (IgH) genes. A domain of feline DNA, termed flvi-1, was
determinants. First, the T-cell origin of the tumors has shown to be interrupted by FeLV proviral integration in
been verified by the demonstration of T-cell receptor b the tumors, implicating flvi-1 as a putative proto-onco-
(TCRb) gene rearrangements (Levy et al., 1988; Levesque gene. The LTRs of FeLV proviruses isolated from the
et al., 1990; Tsatsanis et al., 1994). Second, the involve- tumors were shown not to contain tandemly repeated
ment of a distinctive set of proto-oncogenes, by either enhancer sequences. Rather, they were observed to con-
insertional mutagenesis or retroviral transduction, has tain a unique sequence motif comprised of a 21-base-
pair (bp) tandem triplication beginning 25 bp downstream
of a single copy of the canonical enhancer. The repeated1 To whom correspondence and reprint requests should be ad-
observation of an LTR of this unique structure in tumorsdressed at Department of Microbiology and Immunology, Tulane Medi-
of a distinctive phenotype was thought to implicate thecal School SL38, 1430 Tulane Avenue, New Orleans, LA 70112. Fax:
(504) 588-5144. E-mail: llevy@tmcpop.tmc.tulane.edu. triplication-containing LTR in the induction of tumors of
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that type (Levesque et al., 1990; Athas et al., 1995). The PCR amplification of FeLV LTRs and env gene se-
quences. Primer pair LTR13 and LTR14 were used in PCRanimals from which these tumors were isolated exhibited
extrathymic tumors that, according to the clinical classifi- reactions as previously described (Athas et al., 1995)
to amplify a portion of the LTR from integrated FeLVcation outlined above, would best be characterized as
multicentric. In view of the distinct set of genetic determi- proviruses in tumor DNA. The primers were designed to
yield products of 301 bp from FeLV LTRs containing thenants associated with this limited set of tumors, the ob-
jective of the present study was to examine a larger set 21-bp triplication and 259 bp from LTRs lacking the tripli-
cation. Primer pair env1 and LTR14 were used to amplifyof natural multicentric lymphomas with respect to several
genetic events. First, since the feline TCRb and IgH loci a 2.1-kb fragment of FeLV proviral DNA. The env1 primer
(5*-GGAATGGCCAATCCTAG-3* ) begins at nucleotidehave been characterized to some extent, and probes for
their somatic rearrangement have become available 6073 (of FeLV-A/61E) in a region of the gp70 gene that
is highly conserved among FeLV isolates (Donahue et(Terry et al., 1992, 1995; Tsatsanis et al., 1994), it is possi-
ble to examine the organization of these loci in feline al., 1988). PCR reaction mixtures contained 1 mg of tumor
DNA, 60 pmol of each primer, and a 0.2 mM concentra-lymphomas with increased confidence that somatic re-
arrangement would be detected. The involvement of tion of each deoxyribonucleotide triphosphate, in a reac-
tion buffer of 50 mM KCl, 10 mM Tris, pH 8.4, and 1.5proto-oncogenes implicated in T-cell lymphomagenesis
has also been examined, as has the LTR and gp70 gene mM MgCl2 in a total volume of 100 ml. An initial denatur-
ation step at 987 for 5 min was followed by annealing atstructure of FeLV proviruses in tumor DNA. A pattern of
genetic events associated with FeLV-positive multicen- 577 for 5 min and extension at 727 for 1 min. This was
followed by 35 cycles of denaturation at 947 for 30 sec,tric lymphomas has emerged from this analysis that is
clearly distinct from the pattern observed in FeLV-medi- annealing at 577 for 30 sec, and extension at 727 for 1
min with a final extension for 15 min. Amplification prod-ated T-cell lymphomagenesis.
ucts were examined by agarose gel electrophoresis and
MATERIALS AND METHODS cloned into the pGEM-T plasmid vector (Promega Corp.).
Nucleotide sequence analysis was performed using di-Feline lymphomas. Naturally occurring FeLV-positive
feline tumors examined in this study are of the multicen- deoxy chain termination reactions with Sequenase as
described by the manufacturer (Amersham Life Sci-tric type and have been histopathologically classified as
lymphomas. These tumors were previously examined for ences).
FeLV proviral integration in the c-myc locus (Levy et al.,
1984) and in flvi-1 (Levesque et al., 1990). RESULTS
Probes. The TCRb locus was examined using pFeCb,
a 390-bp fragment derived from the Cb domain of v-tcr TCRb and IgH gene rearrangements in multicentric
lymphomas. Rearrangement of the TCRb gene, a defining(Terry et al., 1992). The IgH locus was examined using
pFeCm4, a 417-bp fragment amplified by PCR from the event in the differentiation of the major ab T-cell lineage,
is characteristic of FeLV-positive feline lymphomas of thefeline IgH locus (Terry et al., 1995). The flvi-2 locus was
examined using probe D, a 1.1-kb EcoRI fragment cloned thymus and reflects their origin in the T-cell lineage. A
recent study demonstrated clonal rearrangement of thefrom feline flvi-2 (Levy and Lobelle-Rich, 1992). The pim-
1 locus was examined using pFePim-1, a 172-bp PCR TCRb gene in 68% of presumptive T-cell lymphomas ex-
amined (Tsatsanis et al., 1994). Organization of the TCRbproduct amplified from exon 5 of feline pim-1 (Tsatsanis
et al., 1994). The fit-1 locus was examined using a 600- locus in the DNA of multicentric lymphomas in the pres-
ent study was examined by Southern blot analysis ofbp PCR product amplified from feline fit-1 (Tsujimoto et
al., 1993). tumor DNA digested with EcoRI or with HincII and hybrid-
ized to a feline Cb-specific probe (Terry et al., 1992). AsSouthern blot analysis. High-molecular-weight geno-
mic DNA was prepared from tumor tissues, and Southern described previously, clonal rearrangements of the feline
TCRb locus can be readily visualized under these condi-blots were prepared, as previously described (Levesque
et al., 1990; Levy and Lobelle-Rich, 1992). Filters were tions (Tsatsanis et al., 1994). Southern blot analysis dem-
onstrated the TCRb locus to be in germ line configurationhybridized for 15 hr in a solution containing 61 SSC, 51
Denhardt solution, 0.5% sodium dodecyl sulfate, 100 mg in all 11 multicentric lymphomas examined (representa-
tive examples shown in Fig. 1), although rearrangementof denatured DNA per milliliter, and 0.05 M PIPES (pH
6.8) at 687 to probes radiolabeled by random priming and was clearly evident in the DNA of 3 thymic lymphomas
examined for comparison (Fig. 1, lanes a–c).added to the hybridization solution at 2 1 106 cpm/ml.
After two washes in 21 SSC–0.1% sodium lauroyl sar- Rearrangement of the IgH locus may be considered a
marker of B-cell lineage, particularly when the TCRb lo-cosine at 377 for 30 min each, and two washes in 0.11
SSC–0.1% sodium lauroyl sarcosine at 557, filters were cus occurs in germ line configuration (Kirsch and Kuehl,
1994). FeLV-associated B-cell lymphomas are relativelyexposed at 0707 for various periods of time to Fuji RX
film, with intensifying screens. rare, although they are generally extrathymic and often
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fragment D (Levy and Lobelle-Rich, 1992). This analysis
allows examination of approximately 9 kilobases (kb) of
feline flvi-2, including the previously described domain of
frequent FeLV integration (Levy and Lobelle-Rich, 1992;
Tsatsanis et al., 1994). Results demonstrated the flvi-2
locus to be in germ line configuration in all 11 multicentric
lymphomas examined (data not shown). The feline pim-
1 and fit-1 loci have been implicated as targets of inser-
FIG. 1. Southern blot analysis of the TCRb locus in DNA from FeLV-
tional mutagenesis in smaller proportions of FeLV-posi-positive lymphomas of cats 981-3 (lane a), 1110 (lane b), 931 (lane c),
tive lymphomas of T-cell origin (2 and 19%, respectively;1043 (lane d), 1046 (lane e), 1112 (lane f ), 945 (lane g), 934 (lane h),
Tsatsanis et al., 1994). Organization of the pim-1 locus1345 (lane i), and from normal feline spleen (lane j). DNA samples
examined were obtained from thymic lymphomas (lanes a–c) or from in the present study was examined after digestion of
extrathymic, multicentric lymphomas (lanes d–i). DNA samples were tumor DNAs with the restriction enzyme EcoRV and hy-
digested with HincII, and resulting Southern blots were hybridized to
bridization to a feline pim-1 exon 5 probe. This analysisa radiolabeled probe representing the Cb domain of feline TCRb (Terry
allows examination of approximately 25 kb of feline pim-et al., 1992). The 9.4- and 3.0-kb fragments definitive of germ line
1, including the sites of integration previously describedorganization of TCRb are indicated. In three thymic lymphomas, clonal
rearrangement of TCRb is evident (lanes a–c). In all multicentric in feline thymic lymphomas (Tsatsanis et al., 1994). Orga-
lymphomas, the locus is in germ line configuration (lanes d–i). nization of the fit-1 locus was examined after digestion
of tumor DNAs with EcoRI, PstI, or BamHI, and hybridiza-
tion to a feline fit-1 probe. This analysis allows examina-associated with the alimentary tract (Cotter, 1992). Orga-
nization of the IgH locus in the DNA of multicentric tion of approximately 26 kb of feline fit-1, including the
major cluster of FeLV proviral integration (Tsujimoto etlymphomas in the present study was examined by South-
ern blot analysis of tumor DNA digested with EcoRI or al., 1993; Tsatsanis et al., 1994). Results demonstrated
both pim-1 and fit-1 loci to be in germ line configurationwith HindIII, and hybridized to a feline Cm-specific probe.
Clonal rearrangements of the feline IgH locus can be in all 11 multicentric lymphomas examined (data not
shown).readily visualized under these conditions (Terry et al.,
1995). Southern blot analysis demonstrated the IgH locus LTRs of FeLV proviruses integrated in multicentric
lymphomas. Previous studies have demonstrated theto be in germ line configuration in all 11 multicentric
lymphomas examined (representative examples shown presence of an FeLV LTR of distinctive structure in four
multicentric lymphomas from the collection examined inin Fig. 2), although an FeLV-negative multicentric tumor
examined for comparison was observed to contain a re- the present study. The unique LTR, not reported in any
other strain of FeLV or in any other mammalian retrovirus,arrangement (Fig. 2, lane e).
Proviral insertional mutagenesis of proto-oncogenes in exhibits a 21-bp tandem triplication beginning 25 bp
downstream of a single copy of the canonical enhancer.multicentric lymphomas. The insertional mutagenesis of
host proto-oncogenes by proviral integration has been Previous studies demonstrated that the 21-bp triplication
contributes enhancer function to the LTR that containsimplicated in FeLV-mediated tumorigenesis. Interruption
of the c-myc, flvi-2 (bmi-1), and pim-1 loci by FeLV provi- it, and that it functions preferentially in a primitive, multi-
potential hematopoietic cell line. Those studies associ-ruses has been linked to the induction of thymic tumors
of T-cell lineage, as has interruption of the putative proto- ated the triplication-containing LTR uniquely with multi-
oncogene, fit-1 (Levy and Lobelle-Rich, 1992; Levy et al.,
1993a,b; Tsujimoto et al., 1993; Tsatsanis et al., 1994).
Involvement of those loci in FeLV-positive multicentric
lymphomas was examined in the present study for com-
parison. Although involvement of the c-myc locus is evi-
dent in 67% of FeLV-positive lymphomas of T-cell origin
(Levy et al., 1993b; Tsatsanis et al., 1994), previous analy-
sis of the multicentric tumors considered in this study
demonstrated the c-myc locus to be in germ line configu-
FIG. 2. Southern blot analysis of the IgH locus in DNA from normal
ration (Levy et al., 1984). The flvi-2 (bmi-1) locus is inter- kitten thymus (lane a), from FeLV-positive, multicentric lymphomas of
rupted by FeLV proviral integration in 25–30% of FeLV- cats 925 (lane b), 945 (lane c), and 1043 (lane d), and from an FeLV-
negative multicentric lymphoma 1316 (lane e). DNA samples were di-positive lymphomas of T-cell origin, as reported in two
gested with HindIII, and the resulting Southern blot was hybridized torecent studies (Levy et al., 1993a; Tsatsanis et al., 1994).
a radiolabeled probe representing the Cm domain of feline IgH (TerryOrganization of the flvi-2 locus in the present study was
et al., 1995). The 8.0-kb fragment definitive of germ line organization
examined after digestion of tumor DNAs with the restric- of IgH is indicated. In FeLV-positive multicentric lymphomas, the locus
tion enzyme PstI or BamHI, and hybridization to a 1.1-kb is in germ line configuration (lanes b–d). By comparison, clonal re-
arrangement of IgH is evident in an FeLV-negative tumor (lane e).EcoRI restriction fragment of feline flvi-2 designated as
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centric tumors, since it was not identified in five thymic sification for FeLV-A and FeLV-C (Rigby et al., 1992; Kris-
tal et al., 1993). Thus, in order to evaluate the subgrouplymphomas examined (Athas et al., 1995). For the present
study, LTRs from seven additional multicentric lympho- classification of triplication-containing FeLV, the se-
quence of the gp70 gene encoding variable regions 1–mas were amplified by PCR (Athas et al., 1995). Amplifica-
tion products were cloned into plasmid vectors, and the 3 was determined. Two FeLV proviruses bearing the trip-
lication-containing LTR were examined. First, a provirussequence of each was determined. LTRs amplified from
four of the tumors (925, 1046, 1043, 1112) were shown was examined that had been previously cloned from a
genomic library of tumor 945 DNA. This provirus wasto contain the 21-bp triplication. Taken together with pre-
vious studies, the triplication-containing LTR has been integrated in tumor DNA at the flvi-1 locus (Levesque et
al., 1990). Second, a 2.1-kb fragment of proviral DNAisolated from eight multicentric lymphomas. The se-
quence and position of the 21-bp triplication is identical containing a portion of the env gene and the LTR was
amplified by PCR from tumor 934 DNA. Because the am-in the LTRs from all of those tumors, with the exception
of a single base change in the LTR amplified from tumor plification product represents viral sequences only, the
integration site of this provirus is not known. Nucleotide925 (Figs. 3 and 4). By comparison, three tumors (1011,
1325, and 1345) were shown to contain LTRs exhibiting sequence analysis of both proviral DNAs verified the
presence of the triplication-containing LTR (data nota single copy of the canonical enhancer and a single
copy of the 21-bp sequence (Fig. 3). Thus, the triplication- shown). Sequence analysis of the gp70 genes revealed
them to be most closely related to FeLV-A/Glasgow. Acontaining LTR is isolated from most, but not all, multi-
centric lymphomas in this collection (8 of 11; 73%). comparison of the predicted translations of gp70 gene
sequences, across variable regions 1–3, from prototypi-PCR amplification yielded multiple products from two
of the tumors examined in the present study. Tumors cal FeLV of subtypes A, B, and C, as well as from triplica-
tion-containing FeLV proviruses is shown in Fig. 6. It can1043 and 1112 were shown to contain not only the tripli-
cation-containing LTR, but also a single-enhancer LTR be seen that the gp70 proteins encoded by triplication-
containing FeLV from two multicentric lymphomas arelacking the triplication (Figs. 3 and 4). Tumor 1112 was
shown to contain a third LTR species that lacks the tripli- nearly, but not entirely, identical to each other and are
most closely homologous to that encoded by FeLV-A/cation, but contains a partial duplication of enhancer.
Specifically, the LTR (indicated as 1112.1 in Fig. 4) con- Glasgow.
tains an imperfect repeat of 28-bp including the core
enhancer and a partial NF1 binding site. This is the only DISCUSSION
amplification product examined among the 11 multicen-
tric lymphomas that exhibits duplication of the canonical Genetic analysis of a set of 11 natural, extrathymic
FeLV-positive lymphomas of multicentric type reveals aenhancer. By contrast, FeLV LTRs derived from thymic
lymphomas typically contain 2 or 3 tandem direct repeats characteristic pattern of molecular determinants. First,
an examination of the TCRb and IgH loci in tumor DNAof the enhancer (Fulton et al., 1990; Matsumoto et al.,
1992; Rohn and Overbaugh, 1995). demonstrates their germ line organization (Figs. 1 and
2). Thus, although the tumors were classified histopatho-gp70 gene sequence from FeLV proviruses bearing the
triplication-containing LTR. Previous studies indicated logically as lymphoid, their lineage and differentiation
state are unknown. By comparison, other studies havethat FeLV proviruses bearing the unique LTR belonged
to subtype A (FeLV-A), inasmuch as molecularly cloned shown that 67–100% of FeLV-positive thymic lymphomas
contain mature T-cells, as evidenced by somatic re-proviral DNA hybridized to a subtype-specific probe that
distinguishes subtypes A and B (Levesque et al., 1990). arrangement of TCRb (Levy and Lobelle-Rich, 1992; Tsat-
sanis et al., 1994). The pattern of proto-oncogene involve-Sequence analysis of the triplication-containing LTR,
however, suggested a relationship to subtype C FeLV ment in thymic lymphomas of T-cell origin is also distinc-
tive, and includes the retroviral transduction or(FeLV-C; Athas et al., 1995). This possibility bears on the
mechanism of pathogenesis mediated by the virus, since insertional mutagenesis of c-myc, flvi-2 (bmi-1), pim-1, or
fit-1 with varying frequencies as high as 67% (Levy andFeLV-A and FeLV-C exhibit quite different pathogenic po-
tentials and induce diseases involving distinct cell popu- Lobelle-Rich, 1992; Levy et al., 1993a,b; Tsujimoto et al.,
1993; Tsatsanis et al., 1994). In fact, 24% of the FeLV-lations (Neil et al., 1991). FeLV subgroup classification
is defined experimentally on the basis of viral interfer- positive T-cell lymphomas examined in a recent study
contained interruptions of more than one of those locience and neutralization properties (Sarma and Log, 1971,
1973). Differences between FeLV-A and FeLV-C with re- within a single tumor, an indication of their cooperation
in T-cell lymphomagenesis (Tsatsanis et al., 1994). Byspect to these properties have been attributed to differ-
ences in the sequence of the amino terminus of gp70 contrast, none of the multicentric lymphomas examined
in the present study exhibited interruption of any of thoseenvelope protein (Neil et al., 1991). In fact, a region of
the gp70 gene that encodes the first three of five variable loci (data not shown). These findings are consistent with
the hypothesis that somatic rearrangement of TCRb, acti-regions has been shown to determine the subgroup clas-
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FIG. 3. Nucleotide sequence of the FeLV LTRs amplified by PCR from naturally occurring feline tumors, shown between the conserved EcoRV
and HincII sites at positions 117 and 232, respectively, in the LTR of FeLV-A/61E (Donahue et al., 1988). Sequences shown include the triplication-
containing FeLV LTRs amplified from lymphomas 945, 934, 922, 1142, 1043, 1046, and 925. LTRs lacking the triplication (trip-) from animals 922,
1142, 1043, 1011, 1325, and 1345 are also shown. Sequences are compared to that of FeLV-945, and only the differences in sequence are shown.
Dashes are included to optimize the alignment due to insertions in the triplication-containing LTRs relative to other sequences. Nuclear protein
binding sites in the FeLV enhancer are indicated (core enhancer, NF1, GRE; Fulton et al., 1990). The sequences of LTRs amplified from tumors
945, 934, 922, and 1142 have been previously reported (Athas et al., 1995).
vation of myc, and proviral insertion at flvi-2, are defining cell lymphomas of the multicentric type suggests the
likelihood that other as yet unidentified proto-oncogenesevents in FeLV-mediated T-cell lymphomagenesis (Levy
et al., 1993b; Tsatsanis et al., 1994). The lack of involve- play a role in their induction. Apparently unique to tumors
of this type is the insertional mutagenesis of flvi-1 byment of myc, flvi-2, pim-1, and fit-1 in non-T-cell non-B-
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FIG. 4. Nucleotide sequence of FeLV LTRs amplified by PCR from a naturally occurring feline tumor, shown between the conserved EcoRV and
HincII sites at positions 117 and 232, respectively, in the LTR of FeLV-A/61E (Donahue et al., 1988). Three distinct LTRs that were amplified (1112.2,
1112.3) or cloned directly (1112.1; Levesque, 1990) from the DNA of tumor 1112 are shown. Sequences are compared to that of 1112.1, and only
the differences in sequence are shown. Dashes are included to optimize the alignment. Nuclear protein binding sites in the FeLV enhancer are
indicated (core enhancer, NF1, GRE; Fulton et al., 1990). A partial NF1 site in the first enhancer repeat is also indicated (NF1).
FeLV proviral integration, as previously described in 4 of be readily distinguished from FeLV-B and FeLV-C by
comparison of amino acid sequence, particularly at the11 (36%) of the tumors examined in this study (Levesque
et al., 1990). The coding capacity of the flvi-1 locus is not amino terminus. Five variable regions in gp70 harbor
most of the mutational changes that distinguish the FeLVyet known.
More striking is the identification of an LTR of unique subtypes (Neil et al., 1991), the first three of which are
known to determine the subgroup classification for FeLV-structure in 8 of 11 (73%) of non-T-cell non-B-cell lympho-
mas of the multicentric type (Figs. 3 and 4). The LTR is A and FeLV-C (Rigby et al., 1992; Kristal et al., 1993). To
examine the subtype classification, and particularly todistinctive in two respects. First, it contains only a single
copy of the enhancer. By comparison, FeLV proviruses evaluate the possibility that triplication-containing FeLV
may be related to subtype C, the sequence of the gp70derived from thymic lymphomas typically contain a tan-
dem direct repeat of two or three copies of the enhancer gene was determined across a region known to encode
determinants of subtype (Rigby et al., 1992; Kristal et al.,(Fulton et al., 1990; Matsumoto et al., 1992; Rohn and
Overbaugh, 1995). Second, the LTR contains a 21-bp se- 1993). Examination of this region of the gp70 gene of
two independent isolates of triplication-containing FeLVquence repeated in tandem, beginning 25 bp down-
stream of the enhancer. This unique LTR, originally de- reveals them to be nearly identical to each other, and
most closely related to FeLV-A (Fig. 5). It is noteworthy,scribed in proviruses integrated at flvi-1 in non-T-cell
non-B-cell lymphomas of the spleen, has been shown to however, that the gp70 genes of FeLV-945 and FeLV-
934, while most closely related to FeLV-A/Glasgow, differfunction preferentially in a primitive, multipotential hema-
topoietic cell line (Athas et al., 1995). Its repeated isola- from it to an extent greater than the known FeLV-A iso-
lates differ from each other. For example, FeLV-945 andtion, uniquely from non-T-cell non-B-cell lymphomas of
the multicentric type, strongly implicates the LTR in the FeLV-934 differ from FeLV-A/Glasgow at 4 of 36 residues
(11%) in variable region 1, and at 2 of 9 residues (22%)induction in tumors of this phenotype.
FeLV proviruses bearing the 21-bp triplication in the in variable region 2. By comparison, three FeLV-A iso-
lates differ across these same regions by only 5 and 0%,LTR were originally classified as members of FeLV sub-
type A, on the basis of hybridization to a probe that distin- respectively, although they were isolated from distant
geographical locations over a period of 13 years (Don-guishes FeLV of subtypes A and B (Levesque et al., 1990).
The possibility that triplication-containing FeLV might ahue et al., 1988). It has been shown that subtle muta-
tional changes accumulate in the gp70 genes of FeLVrepresent subtype C was subsequently suggested by
examination of the LTR sequence (Athas et al., 1995). proviruses in infected animals, and that such changes
may be responsible for biological properties such asThis distinction is important because FeLV subtype clas-
sification is tightly linked to pathogenicity, disease speci- receptor affinity, host range, growth kinetics, and patho-
genic potential (Kristal et al., 1993; Rohn et al., 1994).ficity, and presumably to pathogenic mechanism (Neil et
al., 1991; Jarrett, 1992). The gp70 protein of FeLV-A can Functional studies remain to be performed to evaluate
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FIG. 5. Predicted coding sequences of FeLV gp70env, shown between amino acids 44 and 242 of FeLV-A/Glasgow (Stewart et al., 1986). Sequences
obtained from triplication-containing FeLV proviruses amplified by PCR (FeLV-934) or cloned directly (FeLV-945) from tumor DNA are shown.
Sequences from FeLV-A/Glasgow (Stewart et al., 1986), FeLV-C/Sarma (Riedel et al., 1986), and FeLV-B/Gardner-Arnstein (Elder and Mullins, 1983)
are also shown. Sequences are compared to that of FeLV-A/Glasgow, and only the differences in sequence are shown. Dashes are included to
optimize the alignment. Indicated are the variable regions vr1–vr3 (Neil et al., 1991), and a pentapeptide sequence (MGPNL) representing the major
neutralizing epitope encoded by FeLV env (Elder et al., 1987).
the significance of the distinctive gp70 sequence of tripli- features is required to dissect the pathogenic mecha-
nisms of the FeLV-mediated induction of tumors of thiscation-containing FeLV.
In summary, these findings delineate a set of molecu- type.
lar events associated with the FeLV-mediated induction
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